Replies to post #377980 on Amarin Corp Plc (AMRN)

[HDGabor]

K-

But July 20th is still the decision published date ?

Yes, July 20th is the "Expected publication" date of the appraisal document.
Subject to any appeal, the final appraisal document may be used as the basis for NICE's guidance on using icosapent ethyl in the NHS in England. The guidance recommendation is not intended to affect treatment with icosapent ethyl that was started in the NHS before this guidance was published. People having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS clinician consider it appropriate to stop.
The National Health Service (NHS) is the publicly funded healthcare system in England, and one of the four National Health Service systems in the United Kingdom. It is the second largest single-payer healthcare system in the world after the Brazilian Sistema Único de Saúde.

Any idea on when we hear from Germany

Based on the the date - 17/02/2022 - of the resolution by the G-BA, around 17/08/2022 ... or If parties cannot reach an agreement, the reimbursement price will be set by arbitration around 17/11/2022.

Any idea on when we hear from ... France ?

I am not sure, but based on (i) the the date - 15/12/2021 - of the evaluation and (ii) timeline: 180 days for HAS to determine the acceptable price + 90 days for negotiation about the price: around 15/09/2022.

Best,
G